Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC)

Margaret Camilla Watson, Christine Margaret Bond, Grampian Evidence Based Comm

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

In the UK, there has been a rapid increase in the reclassification of prescription only medicines ( POMs) to pharmacy only ( P) and general sales list (GSL) status. This means that community pharmacy staff have a greater range of non-prescription medicines to recommend for the treatment of minor illness. Strategies are needed to promote good professional practice in the supply of non-prescription medicines. Guidelines have been shown to promote quality of care in other health care settings. In this article, we present evidence based guidelines for the treatment of vulvovaginal candidiasis using non-prescription anti-fungal medicines.

Original languageEnglish
Pages (from-to)129-134
Number of pages5
JournalPharmacy World and Science
Volume25
Issue number4
DOIs
Publication statusPublished - 2003

Keywords

  • community pharmacy
  • evidence-based practice
  • guidelines
  • vulvovaginal candidiasis
  • OVER-THE-COUNTER
  • CLINICAL MANIFESTATIONS
  • SYMPTOMS
  • DIAGNOSIS
  • WOMEN
  • PHARMACISTS
  • MANAGEMENT
  • INFECTIONS
  • YEAST
  • SIGNS

Cite this

Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC). / Watson, Margaret Camilla; Bond, Christine Margaret; Grampian Evidence Based Comm.

In: Pharmacy World and Science, Vol. 25, No. 4, 2003, p. 129-134.

Research output: Contribution to journalArticle

Watson, Margaret Camilla ; Bond, Christine Margaret ; Grampian Evidence Based Comm. / Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC). In: Pharmacy World and Science. 2003 ; Vol. 25, No. 4. pp. 129-134.
@article{e6c99fb891a34e26a00ff28ae3a964fe,
title = "Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC)",
abstract = "In the UK, there has been a rapid increase in the reclassification of prescription only medicines ( POMs) to pharmacy only ( P) and general sales list (GSL) status. This means that community pharmacy staff have a greater range of non-prescription medicines to recommend for the treatment of minor illness. Strategies are needed to promote good professional practice in the supply of non-prescription medicines. Guidelines have been shown to promote quality of care in other health care settings. In this article, we present evidence based guidelines for the treatment of vulvovaginal candidiasis using non-prescription anti-fungal medicines.",
keywords = "community pharmacy, evidence-based practice, guidelines, vulvovaginal candidiasis, OVER-THE-COUNTER, CLINICAL MANIFESTATIONS, SYMPTOMS, DIAGNOSIS, WOMEN, PHARMACISTS, MANAGEMENT, INFECTIONS, YEAST, SIGNS",
author = "Watson, {Margaret Camilla} and Bond, {Christine Margaret} and {Grampian Evidence Based Comm}",
year = "2003",
doi = "10.1023/A:1024819515862",
language = "English",
volume = "25",
pages = "129--134",
journal = "Pharmacy World and Science",
issn = "0928-1231",
publisher = "Kluwer Academic Publishers",
number = "4",

}

TY - JOUR

T1 - Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC)

AU - Watson, Margaret Camilla

AU - Bond, Christine Margaret

AU - Grampian Evidence Based Comm

PY - 2003

Y1 - 2003

N2 - In the UK, there has been a rapid increase in the reclassification of prescription only medicines ( POMs) to pharmacy only ( P) and general sales list (GSL) status. This means that community pharmacy staff have a greater range of non-prescription medicines to recommend for the treatment of minor illness. Strategies are needed to promote good professional practice in the supply of non-prescription medicines. Guidelines have been shown to promote quality of care in other health care settings. In this article, we present evidence based guidelines for the treatment of vulvovaginal candidiasis using non-prescription anti-fungal medicines.

AB - In the UK, there has been a rapid increase in the reclassification of prescription only medicines ( POMs) to pharmacy only ( P) and general sales list (GSL) status. This means that community pharmacy staff have a greater range of non-prescription medicines to recommend for the treatment of minor illness. Strategies are needed to promote good professional practice in the supply of non-prescription medicines. Guidelines have been shown to promote quality of care in other health care settings. In this article, we present evidence based guidelines for the treatment of vulvovaginal candidiasis using non-prescription anti-fungal medicines.

KW - community pharmacy

KW - evidence-based practice

KW - guidelines

KW - vulvovaginal candidiasis

KW - OVER-THE-COUNTER

KW - CLINICAL MANIFESTATIONS

KW - SYMPTOMS

KW - DIAGNOSIS

KW - WOMEN

KW - PHARMACISTS

KW - MANAGEMENT

KW - INFECTIONS

KW - YEAST

KW - SIGNS

U2 - 10.1023/A:1024819515862

DO - 10.1023/A:1024819515862

M3 - Article

VL - 25

SP - 129

EP - 134

JO - Pharmacy World and Science

JF - Pharmacy World and Science

SN - 0928-1231

IS - 4

ER -